New Serotonin 5-HT1A Receptor Agonists Endowed with Antinociceptive Activity in Vivo-Reference-Cited by-同舟云学术

New Serotonin 5-HT1A Receptor Agonists Endowed with Antinociceptive Activity in Vivo

Published:2013-10-08 Issue:20 Volume:56 Page:7851-7861
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Valhondo Margarita¹,Marco Isabel¹,Martín-Fontecha Mar¹,Vázquez-Villa Henar¹,Ramos José A.²,Berkels Reinhard³,Lauterbach Thomas³,Benhamú Bellinda¹,López-Rodríguez María L.¹

Affiliation:

1. Departamento de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain

2. Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universidad Complutense de Madrid, E-28040 Madrid, Spain

3. UCB Pharma GmbH, Alfred-Nobel-Strasse 10, 40789 Monheim, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm400766k

Reference45 articles.

1. Serotonin Receptors

2. The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT1A receptor

3. Arylpiperazine Derivatives Acting at 5-HT1A Receptors

4. Derivatives as 5HT1A Receptor Ligands-Past and Present

5. 5-HT1A Receptor, an Old Target for New Therapeutic Agents

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of aryloxyacetylthiourea derivatives for the development of radicle elongation inhibitor of parasitic weeds;Tetrahedron;2023-04

2. Development and challenges in the discovery of 5-HT1A and 5-HT7 receptor ligands;Bioorganic Chemistry;2023-02

3. Synthesis of aryloxyacetamides from arylboronic acids and 2-bromoacetonitrile promoted by alkaline solutions of hydrogen peroxide;RSC Advances;2023

4. 5-HT1A Serotonergic, α-Adrenergic and Opioidergic Receptors Mediate the Analgesic Efficacy of Vortioxetine in Mice;Molecules;2021-05-28

5. Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist;Journal of Medicinal Chemistry;2020-04-28